Acute intoxication caused by a synthetic cannabinoid in two adolescents.
Travis S Heath, Zachary Burroughs, A Jill Thompson, Frederick W Tecklenburg
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG April 2012 DOI: 10.5863/1551-6776-17.2.177 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 2 |
| Population | Two adolescent patients admitted after inhaling "K2" |
| Keywords | K2 Spice Synthetic cannabinoids |
| Key findings | Two adolescents were admitted after inhaling the synthetic cannabinoid "K2," resulting in loss of consciousness, tachycardia, and diffuse pain. The authors note that pediatric reports of synthetic cannabinoid adverse effects are limited, while cardiovascular effects such as myocardial infarction have been described in a recent pediatric case series. |
Abstract
Illicit drug use continues to be a common problem among pediatric patients. Daily marijuana use among high school seniors is currently at a 30-year high. Marijuana use in adults has rarely been associated with cardiovascular adverse effects, including hypertension, tachycardia, arrhythmia, and myocardial infarction. Recently, abuse of synthetic cannabinoids, such as the incense "K2" or "Spice," has been increasingly reported in the lay press and medical literature. Overdose and chronic use of these substances may cause adverse effects including altered mental status, tachycardia, and loss of consciousness. Overdoses in adult patients have been described; however, limited reports in the pediatric population have been documented. A recent case series describes myocardial infarctions in pediatric patients, associated with synthetic cannabinoid use. In this report, we describe two adolescent patients admitted after they inhaled "K2," resulting in loss of consciousness, tachycardia, and diffuse pain.
Citations in the library
Cited by 5
- Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital. Clinical medicine May 4, 2021
- Fatal intoxication with synthetic cannabinoid MDMB-CHMICA. Forensic Science International April 1, 2016
- Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies. Journal of Medical Toxicology December 1, 2015
- Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence November 1, 2014
- Spicing things up: synthetic cannabinoids. Psychopharmacology July 9, 2013
Cites 4
- JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. British Journal of Pharmacology June 2010
- Cannabis and psychosis/schizophrenia: human studies European Archives of Psychiatry and Clinical Neuroscience July 16, 2009
- Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Deutsches Arzteblatt international July 3, 2009
- Adverse effects of cannabis on health: an update of the literature since 1996. Progress in neuro-psychopharmacology & biological psychiatry August 2004